Colon Cancer Rates Surge in Older Americans, Reversing Decades of Progress
A new study reveals an increase in colon cancer diagnoses among older adults, a worrying trend that experts say could undermine previous prevention efforts.
Colon cancer rates in the United States are increasing among older Americans for the first time in two decades, a reversal of a long-standing decline in diagnoses. This trend is raising concerns among medical experts who fear that previously unidentified risk factors may be eroding the gains made through decades of public health initiatives and screening.
Researchers examined national cancer data from 2000 to 2023 and found that while colorectal cancer rates had steadily fallen by approximately one-third between 2000 and 2022, they rose by 4% in 2023. This increase was observed across different age groups up to age 69, and notably, it occurred even in individuals who were up to date with recommended screenings.
The study, published in NEJM Evidence, suggests a potential "birth cohort effect," where individuals born in certain decades may possess a higher inherent risk of developing the disease compared to previous generations at the same age. Researchers suspect that those born during or after the 1960s might have encountered environmental or lifestyle factors to a greater extent, which could contribute to increased cancer rates as they age.
While previous research has linked colorectal cancer to factors such as obesity, physical inactivity, smoking, alcohol consumption, and diets high in processed meats, the current study did not pinpoint specific causes for the recent rise. Experts are exploring various hypotheses, including the potential impact of disruptions to routine cancer screening during the COVID-19 pandemic, though statistical models indicate the increase continues even after accounting for pandemic-related delays.
Colorectal cancer is the fourth most common cancer and the second leading cause of cancer-related death in the United States, with approximately 55,000 deaths attributed to the disease annually. Standard screening recommendations typically advise individuals aged 45 to 75 to undergo regular screening, including stool sample tests or colonoscopies every 10 years, which are effective in detecting and removing precancerous growths.
The current findings highlight a significant shift, as previous efforts had led to substantial reductions in colon cancer rates since the early 2000s. The new data indicates that these positive trends may be plateauing or reversing, prompting a call for further investigation into the underlying causes and a potential reevaluation of prevention strategies.